戻る
Biontech SE (BNTX)価格
BNTX 株価推移チャート
BNTX 収入
Biontech SE
$109
2.76%
$2.93
終値： Jan 16, 16:00:00 GMT-5
$106.51
-2.28%
$-2.48
プレマーケット： Jan 20, 07:59:28 GMT-5
主要データ
前終値
$106.07
始値
$109.24
当日レンジ
$106.51 - $111.26
52週レンジ
$81.2 - $126.77
取引高
1.1M
平均取引高
1.0M
1株当たり利益(TTM)
-2.36
配当利回り
0.00%
時価総額
$25.6B
BNTXとは何ですか？
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. The company is headquartered in Mainz, Rheinland-Pfalz and currently employs 6,772 full-time employees. The company went IPO on 2019-10-10. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The firm is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. The company also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.